Table 2 Characteristics of the 185 patients with B‐type natriuretic (BNP) samples.
All patients (n = 185) | Patients with no IHD or cardiac failure (n = 121) | Patients with IHD or cardiac failure (n = 64) | |
---|---|---|---|
Age (years) | 58.6 (10) | 57 (10) | 65 (7)*** |
Sex (male/female) | 109/76 | 74/47 | 35/29 |
Smoking (no/yes) | 147/38 | 93/28 | 54/10 |
Hypertension (no/yes) | 100/85 | 58/63/ | 42/22/ |
Hyperlipidaemia (no/yes) | 132/53 | 90/31 | 42/22 |
Haemoglobin A1c (%) | 7.79 (1.5) | 7.6 (1.5) | 7.8 (1.3) |
Cholesterol (mmol/l) | 5.3 (1.3) | 5.3 (1.5) | 5.3 (0.9) |
SBP (mm Hg) | 142 (21) | 142 (21) | 145 (15) |
DBP (mm Hg) | 82 (11) | 81 (10) | 79 (10) |
BMI (kg/m2) | 30.1 (5.98) | 31 (5.9) | 30 (5.1) |
BNP (pg/ml) | 32.0 (30.6) | 29.8 (25.7) | 44.7 (38.0) |
Data are described as patient number (%), median (interquartile range) for BNP or mean (SD).
***p<0.001 between the ischaemic heart disease (IHD) or cardiac failure and the no IHD or cardiac failure groups.
BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.